Mereo Biopharma Group Stock Forecast

Buy or Hold candidate since Jun 29, 2026 Loss -3.25%

The Mereo Biopharma Group Plc stock price fell by -4.18% on the last day (Monday, 13th Jul 2026) from $0.335 to $0.321. During the last trading day the stock fluctuated 4.87% from a day low at $0.316 to a day high of $0.331. The price has risen in 6 of the last 10 days and is up by 8.23% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -694 thousand shares and in total, 654 thousand shares were bought and sold for approximately $210.05 thousand.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 10.83% during the next 3 months and, with a 90% probability hold a price between $0.292 and $0.402 at the end of this 3-month period.

MREO Signals & Forecast

The Mereo Biopharma Group Plc stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $0.326. On a fall, the stock will find some support from the long-term average at approximately $0.316. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, May 28, 2026, and so far it has fallen -6.96%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Mereo Biopharma Group Plc stock

Mereo Biopharma Group Plc finds support from accumulated volume at $0.305 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0154 between high and low, or 4.87%. For the last week the stock has had daily average volatility of 7.02%.

Our recommended stop-loss: $0.304 (-5.41%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 30 days ago.)

Trading Expectations (MREO) For The Upcoming Trading Day Of Tuesday 14th

For the upcoming trading day on Tuesday, 14th we expect Mereo Biopharma Group Plc to open at $0.323, and during the day (based on 14 day Average True Range), to move between $0.306 and $0.336, which gives a possible trading interval of +/-$0.0291 (+/-9.48%) up or down from last closing price. If Mereo Biopharma Group Plc takes out the full calculated possible swing range there will be an estimated 9.48% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.329 (2.40%) than the support at $0.305 (4.98%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Mereo Biopharma Group Plc stock A Buy?

Mereo Biopharma Group Plc holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold candidate.

Current score: 0.604 Hold/Accumulate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on July 14, 2026 - $0.323 ( 0.561%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk